GXM3 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to GXM3 Antibodies

GXM3 antibodies refer to IgG3 subclass immunoglobulins targeting glucuronoxylomannan (GXM), a capsular polysaccharide of Cryptococcus neoformans. GXM is a major virulence factor that suppresses host immunity by interacting with inhibitory Fcγ receptors (e.g., FcγRIIB) and dampening inflammatory responses . IgG3 antibodies against GXM are critical for reversing this immunosuppression and mediating protective immune responses, including opsonization, complement activation, and antibody-dependent cellular cytotoxicity (ADCC) .

Efficacy in Immune Response

IgG3 antibodies against GXM exhibit variable protective efficacy depending on their isotype and epitope specificity:

Isotype-Switching Efficacy

Isotype switching non-protective IgG3 MAbs (e.g., 3E5, 4H3) to IgG1, IgG2a, or IgG2b improves protection against C. neoformans infection .

AntibodyIsotypeEfficacy (Mouse Model)
3E5IgG3Non-protective
3E5IgG1Moderate protection
3E5IgG2bStrong protection
4H3IgG3Disease-enhancing
4H3IgG2bStrong protection

Mechanisms of Action

  • Opsonization: IgG3 promotes phagocytosis via Fcγ receptors but less effectively than IgG2b .

  • GXM Neutralization: Specific IgG3 MAbs (e.g., 12A1, 18B7) inhibit GXM release from C. neoformans, reducing serum polysaccharide levels .

  • Complement Activation: IgG3 binds C1q with higher affinity than other IgG subclasses, facilitating complement-dependent cytotoxicity (CDC) .

Clinical and Therapeutic Implications

  • Passive Immunotherapy: IgG3 antibodies (e.g., 18B7) reverse GXM-mediated immunosuppression by engaging activating FcγRIII instead of inhibitory FcγRIIB .

  • Half-Life Limitations: Shorter half-life of IgG3 reduces therapeutic persistence, necessitating allotype selection (e.g., IGHG317) for extended protection .

  • Vaccine Development: IgG3 antibodies with cross-reactivity to multiple GXM motifs (e.g., M2 and M4) are critical for broad-spectrum protection .

Epitope Specificity and Protective Efficacy

Cross-reactivity to GXM motifs correlates with antibody efficacy:

AntibodyEpitope SpecificityProtective Outcome
12A1M2, M4Protective
18B7M2, M4Protective
3E5-IgG3M2Non-protective
4H3-IgG3M2Disease-enhancing

GXM Release Inhibition

IgG3 MAbs reduce GXM shedding in vitro, as shown in C. neoformans cultures:

AntibodyGXM Concentration (μg/ml)Reduction vs. Control
18B72550%
12A12540%
13F12510%

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
GXM3 antibody; At1g33800 antibody; F14M2.8 antibody; Glucuronoxylan 4-O-methyltransferase 3 antibody; EC 2.1.1.112 antibody
Target Names
GXM3
Uniprot No.

Target Background

Function

GXM3 Antibody is a methyltransferase that catalyzes the 4-O-methylation of glucuronic acid side chains on xylan.

Gene References Into Functions
  1. The activities of GXM1, GXM2, and GXM3 are responsible for all glucuronic acid (GlcA) methylation in xylan within plant stems. The degree of GlcA methylation in xylan can be modified by altered expression of GXMs. PMID: 24576763
  2. An Arabidopsis gene (At1g33800) encodes a cation-dependent glucuronoxylan methyltransferase (GXMT) that specifically methylates the O-4 position of the GlcA substituents of glucuronoxylan. PMID: 22893684
Database Links

KEGG: ath:AT1G33800

STRING: 3702.AT1G33800.1

UniGene: At.28328

Protein Families
Methyltransferase superfamily
Subcellular Location
Golgi apparatus membrane; Single-pass membrane protein.
Tissue Specificity
Expressed in hypocotyls, roots, rosette leaves, stems and siliques.

Q&A

What are the different types of GXM3 antibodies available for research?

GXM3 antibodies fall into two main categories based on target proteins with similar abbreviations. The first targets GSTM3 (Glutathione S-transferase Mu 3), a human protein involved in detoxification processes. This is typically available as a rabbit polyclonal antibody suitable for immunohistochemistry and western blotting . The second targets plant GXM3 (Glucuronoxylan 4-O-methyltransferase 3), available as mouse monoclonal antibodies that react with Arabidopsis thaliana and Populus deltoids . Understanding which GXM3 variant your research focuses on is crucial for selecting the appropriate antibody.

What are the key biological functions of GXM3/GSTM3 proteins?

Human GSTM3 functions in the conjugation of reduced glutathione to a wide range of exogenous and endogenous hydrophobic electrophiles. Notably, it may govern the uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers . In plants, GXM3 (Glucuronoxylan 4-O-methyltransferase 3) serves as a methyltransferase that catalyzes 4-O-methylation of glucuronic acid side chains on xylan . This enzyme is typically localized in the Golgi apparatus, highlighting its role in cell wall polymer synthesis and modification.

How do I determine the appropriate antibody format for my GXM3 research?

The optimal antibody format depends on your experimental needs and target system. For human GSTM3, rabbit polyclonal antibodies have been validated for IHC-P and western blot applications . These recognize epitopes within the C-terminal region (amino acids 150 to C-terminus) of human GSTM3. For plant research, mouse monoclonal antibodies against Arabidopsis GXM3 are available for western blot and ELISA applications . Consider your experimental system (human vs. plant), required applications, and the specific epitope region when selecting between available formats.

What are the validated applications for GXM3/GSTM3 antibodies?

For human GSTM3 antibodies, validated applications include:

  • Western blot (WB): Effective at 0.4 μg/ml concentration

  • Immunohistochemistry on paraffin-embedded sections (IHC-P): Functioning at 1/500 dilution

For plant GXM3 antibodies:

  • Western blot (WB): Working dilutions vary by antibody

  • ELISA: Recommended dilutions range from 1:1000-1:3000

The choice of application should be guided by your specific research question and experimental system.

What protocols yield optimal results for western blot using GXM3 antibodies?

For optimal western blot results with GXM3 antibodies, follow this methodological approach:

  • Separate proteins on a 4-15% polyacrylamide gradient gel

  • Transfer to a nitrocellulose membrane

  • Block with 5% non-fat milk in TBST

  • Incubate with GXM3 antibody (1:500 dilution) overnight at 4°C

  • Wash three times (5 minutes each) with TBST

  • Incubate with HRP-conjugated anti-mouse or anti-rabbit IgG secondary antibody for 1 hour at room temperature

  • Wash three times with TBST

  • Visualize using ECL detection system

When working with human GSTM3, expect a band at approximately 25-27 kDa . For plant GXM3, band sizes may vary based on the specific target protein.

How should I approach immunofluorescence staining with GXM3 antibodies?

For effective immunofluorescence staining with GXM3 antibodies:

  • Prepare tissue sections (paraffin embedding works well for both plant and human tissues)

  • Block sections with appropriate serum (e.g., goat serum) at 37°C for 30 minutes

  • Incubate with GXM3 antibody (1:500 dilution) overnight at 4°C

  • Wash three times with PBS (10 minutes each)

  • Incubate with fluorophore-conjugated secondary antibody (e.g., Alexa Fluor 488 anti-mouse or anti-rabbit IgG at 1:1000 dilution) for 1 hour at room temperature

  • Wash three times with PBS

  • Counterstain with DAPI (1.5 mg/mL) in antifade medium

  • Examine using fluorescence microscopy

This protocol has been successfully used for detecting GXM3 in Arabidopsis inflorescence sections and can be adapted for human tissues.

How do I verify the specificity of my GXM3 antibody?

Verifying antibody specificity is critical for reliable results. Recommended validation approaches include:

  • Knockout control testing: For human GSTM3, compare antibody binding in wild-type cells versus GSTM3 knockout cell lines. A specific antibody will show signal at the expected size (25-27 kDa) in wild-type but not in knockout samples .

  • Multiple detection methods: Confirm your findings using at least two independent techniques (e.g., western blot and immunohistochemistry).

  • Immunoprecipitation and mass spectrometry: Enrich for putative antigens using the antibody, then identify the precipitated proteins via mass spectrometry to confirm target identity .

  • Peptide competition assay: Pre-incubate the antibody with a synthetic peptide corresponding to the immunogen to block specific binding.

What are common troubleshooting issues with GXM3 antibody applications?

When working with GXM3 antibodies, researchers frequently encounter these challenges:

IssuePotential CausesSolutions
No signal in western blotInadequate protein extraction, improper antibody dilution, protein degradationOptimize extraction protocol, adjust antibody concentration, add protease inhibitors
Multiple bandsCross-reactivity, protein degradation, alternative splicingIncrease blocking, optimize antibody dilution, use fresh samples
High backgroundInsufficient blocking, excessive antibody, non-specific bindingIncrease blocking time/concentration, reduce antibody concentration, optimize wash steps
Inconsistent staining in IHCFixation issues, antigen masking, variable expressionOptimize fixation protocol, try antigen retrieval, ensure consistent processing

For human GSTM3 antibodies, interexperimental variation has been observed, but statistical significance can be achieved with sufficient replication .

What controls should I include when using GXM3 antibodies?

Rigorous experimental design requires appropriate controls:

  • Negative controls:

    • Primary antibody omission

    • Isotype control antibody (e.g., irrelevant IgG of the same species)

    • Knockout or knockdown samples when available

  • Positive controls:

    • Tissues/cells known to express the target (e.g., testis tissue for human GSTM3 )

    • Recombinant protein expressing the target antigen

  • Loading controls:

    • For western blot, include housekeeping proteins (e.g., alpha-tubulin) to normalize expression

    • For IHC/IF, include tissues with known expression patterns for comparison

How can GXM3 antibodies be utilized in studies of protein-protein interactions?

GXM3 antibodies can facilitate protein interaction studies through several methodological approaches:

  • Co-immunoprecipitation (Co-IP):

    • Use GXM3 antibodies to precipitate the target protein and its binding partners

    • Analyze co-precipitated proteins by western blot or mass spectrometry

    • Maintain native conditions during extraction to preserve protein-protein interactions

  • Proximity ligation assay (PLA):

    • Combine GXM3 antibody with antibodies against putative interacting partners

    • Detect protein proximity (< 40 nm) through rolling circle amplification

    • Visualize interaction events as fluorescent spots

  • Immunofluorescence co-localization:

    • Perform dual-labeling with GXM3 antibody and antibodies against potential interactors

    • Analyze co-localization using confocal microscopy and quantitative image analysis

    • Calculate correlation coefficients to measure association strength

These approaches can reveal functional relationships between GXM3/GSTM3 and other cellular components.

What considerations are important when using GXM3 antibodies in cross-species studies?

When using GXM3 antibodies across different species, consider these methodological factors:

  • Epitope conservation:

    • Evaluate sequence homology in the antibody's epitope region between species

    • For plant GXM3, antibodies raised against Arabidopsis have demonstrated cross-reactivity with Populus deltoids (cottonwood)

    • For GSTM3, expect potential cross-reactivity with closely related mammals based on sequence conservation

  • Validation approach:

    • Always validate antibody reactivity in each new species

    • Begin with western blot to confirm binding to a protein of expected size

    • Proceed to other applications only after initial validation

  • Application optimization:

    • Titrate antibody concentrations for each new species

    • Modify blocking conditions to minimize non-specific binding

    • Adjust incubation times and temperatures based on empirical testing

How can immunoprecipitation and mass spectrometry be combined to identify GXM3 targets?

This advanced approach can identify protein targets and complexes:

  • Immunoprecipitation procedure:

    • Add GXM3 antibody to protein extract and incubate for 2 hours at 4°C

    • Introduce protein A-conjugated beads and incubate for 1 hour

    • Collect beads by centrifugation (2000g, 2 minutes, 4°C)

    • Wash thoroughly with TBST to remove non-specific binders

    • Elute bound proteins by boiling in SDS loading buffer for 10 minutes

  • Sample preparation for mass spectrometry:

    • Separate eluted proteins by SDS-PAGE

    • Perform silver staining to visualize protein bands

    • Excise bands of interest for tryptic digestion

    • Extract peptides for mass spectrometry analysis

  • Data analysis:

    • Compare immunoprecipitated samples with controls (isotype-matched irrelevant antibody)

    • Identify proteins enriched in experimental samples

    • Validate findings through independent methods (western blot, functional assays)

This combined approach has successfully identified target antigens for monoclonal antibodies generated against plant proteins .

What potential roles does GSTM3 play in detoxification mechanisms at tissue barriers?

Current research indicates that human GSTM3 may govern the uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers . This suggests important physiological roles in:

  • Protection against toxic compounds: GSTM3 mediates conjugation of reduced glutathione to exogenous and endogenous hydrophobic electrophiles, potentially preventing damage to sensitive tissues.

  • Blood-tissue barrier function: Expression at these critical interfaces suggests a role in selective permeability and protection of tissues with specialized functions.

  • Specialized detoxification systems: GSTM3 may provide tissue-specific detoxification mechanisms that complement liver-based metabolism.

Future research using GSTM3 antibodies could explore the cellular distribution within these barrier tissues, regulation under various toxicological challenges, and potential clinical implications in barrier dysfunction disorders.

How are plant GXM3 antibodies contributing to understanding plant cell wall development?

Plant GXM3 (Glucuronoxylan 4-O-methyltransferase 3) catalyzes the 4-O-methylation of glucuronic acid side chains on xylan, a major component of secondary cell walls . Antibodies against GXM3 are enabling researchers to:

  • Map the spatiotemporal expression of GXM3 during plant development, particularly in tissues undergoing secondary cell wall formation.

  • Explore the subcellular localization and trafficking of GXM3 within the Golgi apparatus, elucidating the organization of cell wall synthesis machinery.

  • Investigate regulatory mechanisms controlling GXM3 expression and activity in response to developmental and environmental signals.

This research has implications for understanding fundamental plant biology and potential applications in improving biomass properties for biofuel production and other industrial applications.

What methodological advances are improving antibody development for plant research?

Recent methodological advances in generating and validating plant-specific antibodies include:

  • Total protein immunization approach: Using complex mixtures of proteins from specific plant tissues (e.g., inflorescences) as immunogens to generate diverse antibody libraries .

  • Multi-stage screening strategies: Employing sequential western blot, immunofluorescence, and mass spectrometry-based target identification to fully characterize antibody specificity and utility .

  • Tissue-specific expression categorization: Classifying antibodies based on their reactivity patterns (tissue-specific, preferential, or broad expression) to identify the most useful reagents for particular research questions .

These approaches have successfully generated antibodies that serve as valuable molecular markers for studying developmental processes in plants, including floral organ development .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.